Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells
<b>Background:</b> Immunotherapy has changed the options for the treatment of various cancer types, but not colon cancer. Current checkpoint blockade approaches are ineffective in a large proportion of colon cancer cases, necessitating studies to elucidate its mechanisms and to identify...
Main Authors: | Deepa Bedi, Henry J. Henderson, Upender Manne, Temesgen Samuel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Medicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2305-6320/6/2/51 |
Similar Items
-
Different Camptothecin Sensitivities in Subpopulations of Colon Cancer Cells Correlate with Expression of Different Phospho-Isoforms of Topoisomerase I with Different Activities
by: Cinzia Tesauro, et al.
Published: (2020-05-01) -
The combination of olaparib and camptothecin for effective radiosensitization
by: Miura Katsutoshi, et al.
Published: (2012-04-01) -
Examining the association between BRCA1 and topoisomerase I in cancer cells in response to camptothecin treatment
by: Godley IV, Frederick Augustus
Published: (2016) -
Rôle de la GTPase Rho RND1 dans la réponse cellulaire à la camptothécine, inhibiteur de la topoisomérase I
by: Mouly, Laetitia
Published: (2018) -
Cellular Basis of Antiproliferative and Antitumor Activity of the Novel Camptothecin Derivative, Gimatecan, in Bladder Carcinoma Models
by: Paola Ulivi, et al.
Published: (2005-02-01)